Findings

What do systematic reviews say?

1,655 questions · 1,751 findings · 147 reviews · Pain, Palliative and Supportive Care

Sort:Best matchNewestHighest certainty Download CSV

No studies found 361 · 20.6%GRADE not reported 87 · 5%Very low 625 · 35.7%Low 367 · 21%Moderate 232 · 13.2%High 79 · 4.5%

Topical NSAIDs vs topical placebo

All topical NSAIDs Local adverse events · adults with strains, sprains, or muscle pull

1 finding from 1 review

Topical NSAIDs for acute musculoskeletal pain in adults 2015 · Cochrane Headline outcomes only
no estimate extracted
42 studies · 6125 participants
High

Topical NSAIDs vs topical placebo

All topical NSAIDs Systemic adverse events · adults with strains, sprains, or muscle pull

1 finding from 1 review

Topical NSAIDs for acute musculoskeletal pain in adults 2015 · Cochrane Headline outcomes only
no estimate extracted
38 studies · 5372 participants
High

Topical NSAIDs vs topical placebo

All topical NSAIDs Withdrawals ‐ adverse events · adults with strains, sprains, or muscle pull

1 finding from 1 review

Topical NSAIDs for acute musculoskeletal pain in adults 2015 · Cochrane Headline outcomes only
no estimate extracted
42 studies · 5790 participants
High

Topical NSAIDs vs topical placebo

Serious adverse events · adults with strains, sprains, or muscle pull

1 finding from 1 review

Topical NSAIDs for acute musculoskeletal pain in adults 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Intervention not reported

Milnacipran 100 mg/day · adults with fibromyalgia

1 finding from 1 review

Milnacipran for pain in fibromyalgia in adults 2015 · Cochrane Headline outcomes only
no estimate extracted
100 participants
GRADE not reported

Intervention not reported

At least 50% reduction in pain or equivalent (substantial) · adults with fibromyalgia

1 finding from 1 review

Milnacipran for pain in fibromyalgia in adults 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1250 participants
Moderate

Intervention not reported

At least 30% reduction in pain or equivalent (moderate) · adults with fibromyalgia

1 finding from 1 review

Milnacipran for pain in fibromyalgia in adults 2015 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 1925 participants
High

Intervention not reported

Adverse event withdrawals · adults with fibromyalgia

1 finding from 1 review

Milnacipran for pain in fibromyalgia in adults 2015 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 2379 participants
High

Intervention not reported

Serious adverse events · adults with fibromyalgia

1 finding from 1 review

Milnacipran for pain in fibromyalgia in adults 2015 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 2378 participants
Low

Intervention not reported

Death · adults with fibromyalgia

The review found no eligible studies for this question.

1 finding from 1 review

Milnacipran for pain in fibromyalgia in adults 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Milnacipran 200 mg/day · adults with fibromyalgia

1 finding from 1 review

Milnacipran for pain in fibromyalgia in adults 2015 · Cochrane Headline outcomes only
no estimate extracted
200 participants
GRADE not reported

Intervention not reported

Cry duration · Children 1‐16 years undergoing needle‐related procedures Summary of sub‐analysis findings: Children 1‐4 years: Cry time

1 finding from 1 review

Sweet tasting solutions for reduction of needle‐related procedural pain in children aged one to 16 years 2015 · Cochrane Headline outcomes only
no estimate extracted
520 participants
Low

Intervention not reported

Change in short‐term disability (function) FIM motor · 106 participants with primary brain tumour

1 finding from 1 review

Multidisciplinary rehabilitation after primary brain tumour treatment 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 106 participants
Low

Intervention not reported

Change in long‐term QoL CARES‐SF (global) · 106 participants with primary brain tumour

1 finding from 1 review

Multidisciplinary rehabilitation after primary brain tumour treatment 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 106 participants
Low

Intervention not reported

Change in other outcomes · 106 participants with primary brain tumour

The review found no eligible studies for this question.

1 finding from 1 review

Multidisciplinary rehabilitation after primary brain tumour treatment 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Cost‐ effectiveness · 106 participants with primary brain tumour

1 finding from 1 review

Multidisciplinary rehabilitation after primary brain tumour treatment 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 106 participants
GRADE not reported

Intervention not reported

Serious adverse events · 106 participants with primary brain tumour

1 finding from 1 review

Multidisciplinary rehabilitation after primary brain tumour treatment 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 106 participants
GRADE not reported

Intervention not reported

Change in short‐term disability (cognition) FIM cognition · 106 participants with primary brain tumour

1 finding from 1 review

Multidisciplinary rehabilitation after primary brain tumour treatment 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 106 participants
Low

Intervention not reported

Change in long‐term disability (function) FIM motor · 106 participants with primary brain tumour

1 finding from 1 review

Multidisciplinary rehabilitation after primary brain tumour treatment 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 106 participants
Low

Intervention not reported

Change in long‐term disability (cognition) FIM cognition · 106 participants with primary brain tumour

1 finding from 1 review

Multidisciplinary rehabilitation after primary brain tumour treatment 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 106 participants
Low